Endocrine effects of recombinant interleukin 6 in man

Neuroendocrinology

Volumn 63, Issue 3, 1996, Pages 237-243

  Späth Schwalbe, Ernst ^a,b,c,d   Schrezenmeier, Hubert ^a,b,c,d   Bornstein, Stefan ^a,b,c,d   Burger, Klaus ^a,b,c,d   Porzsolt, Franz ^a,b,c,d   Born, Jan ^a,b,c,d  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Sandoz Pharma Ltd   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Gonadal steroids; Gonadotropins; Growth hormone; Interleukins; Prolactin; Thyroid hormones; Thyrotropin

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; RECOMBINANT INTERLEUKIN 6; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RELEASE; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

CARCINOMA, RENAL CELL; HORMONES; HUMANS; INTERLEUKIN-6; KIDNEY NEOPLASMS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TESTOSTERONE; THYROXINE; TRIIODOTHYRONINE;

EID: 0030033325     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000126963     Document Type: Article

References (38)

1. Bauer J, Herrmann F: lnterleukin-6 in clinical medicine, Ann Hcmatol 1991:62:203-210.
2. Weber J, Yang C, Topalian SL, Parkinson DR, Schwartzcntruber DS, Ettinghausen SE, Gunn H, Mixon A, Kim H, Cole D, Levin R, Rosenberg SA: Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies, J Clin Oncol 1993;11:499-506.
3. Van Gameren MM, Willemse PHB, Mulder NH, Limburg PC, Grocn HJ, Vellenga E, De Vries EG: Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study, Blood 1994:84:1434-1441.
4. Schrezenmeier H, Späth-Schwalbc E, Drechsler S, Färber L, Stromcver P, Porzsolt F, Heim-pel H, Raghavachar A: Phase I trials of interleukin-6 in patients with advanced renal cell carcinoma and patients with aplastic anemia: Effects of longterm application and differences of hemopoietic responses to IL-6 in patients with normal hemopoiesis versus patients with aplastic anemia, Blood 1993;82:368a.
5. Imura H, Fukata J, Mori T: Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems, Clin Endocrinol 1991:35:107-115.
6. Gorospe WC, Spangclo BL: Interleukin-6: Potential roles in neuroendocrine and ovarian function, EndocrJ 1993;1:3-9.
7. Woloski BM, Smith EM, Meyer WJ, Fuller GM, Blalock JE: Corticotropin-rclcasing activity of monokines, Science 1985:230:1035-1037.
8. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tarnai S, Mori K, Imura H: lnterleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats, Bio-chent Biophys Res Commun 1988:155:1459-1463.
9. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB: lnterleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from the rat hypothalamus in vitro via the cicosanoid cyclooxygenase pathway, Endocrinology 1991; 128:37-44.
10. Lyson K, McCann SM: The effect of interleukin-6 on pituitary hormone release in vivo and in vitro, Neuroendocrinology 1991:54:262-266.
11. Spinedi H, Hadid R, Daneva T, Gaillard RC: Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of intcrleukin-6 action, Ncuroendocrinology 1992:56:46-53.
12. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypolha-lamic-pituitary-adrenal axis in humans, J Clin Endocrinol Metab 1993;77:1690-1694.
13. Späth-Schvvalbe E, Bom J, Schrezenmeicr H, Bomstcin SR, Stromcycr P, Drechsler S, Fehm HL, Porzsolt F: Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man, J Clin Endocrinol Metab 1994;79:1212-1214.
14. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP: Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: Potential implications for the syndrome of inappropriate vasopressin secretion, J Clin Endocrinol Metab 1994;79:934-939.
15. Spangelo BL, Judd AM, Isakson PC, MacLeod M: Interleukin-6 stimulates anterior pituitary hormone release in vitro, Endocrinology 1989; 125:575-577.
16. Yamaguchi M, Matsuzaki N, Hirota K, Miyake A, Tanizawa O: Interleukin 6 possibly induced by interleukin lß in the pituitary gland stimulates the release of gonadotropins and prolactin, Acta Endocrinol (Copenh) 1990:122:201-205.
17. Stouthard JML, Van der Poll T, Endert E, Bak-ker PJM, Veenhof CHN, Sauerwein HP, Ro-mijn JA: Effects of acute and chronic intcrleukin-6 administration on thyroid hormone metabolism in humans, J Clin Endocrinol Metab 1994:79:1342-1346.
18. Hcney D, Lewis HJ, Evans SW, Banks R, Bailey CC, Whichcr JT: Intcrleukin-6 and its relationship to C-rcactivc protein and fever in children with febrile neutropenia, J Infect Dis 1992; 165: 886-890.
19. Engel A, Kem WV, Miirdter G, Kem P: Kinetics and correlation with body temperature of circulating inlerleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with lever and neutropenia, Infection 1994;22:160-164.
20. Van Haasteren GAC, Van der Meer MJM, Hcrmus ARMM, Linkels E, KJootwijk W, Kap-tein E, Van Toor H, Sweep CGJ, VisserTJ, Dc Greef WJ: Different effectsofcontinuous infusion of interleukin-1 and interlcukin-6 on the hypothalamic-hypophysial-thyroid axis, Endocrinology 1994;135:1336-1345.
21. Bartalena L, Grasso L, Brogioni S, Martino E: Interleukin 6 effects on the pituitary-thyroid axis in the rat. EurJ Endocrinol 1994; 131:302-306.
22. Lyson K, Milenkovic L, McCann SM: The stimulatory effect of intcrleukin-6 on corticotropin-releasing factor and thyrotropin releasing hormone secretion in vitro (abstract), 20th Annual Meeting of the Society for Neuroscience, St Louis 1990, p 1212.
23. Scarborough DE: Somatostatin regulation by cytokines, Metabolism 1990:39 (suppl 2): 108-111.
24. Toni R, Lcchan RM: Neuroendocrine regulation of thyrotropin-releasing hormone (TRH) in the tuberoinl'undibular system, J Endocrinol Invest 1993:16:715-753.
25. Spangelo BL, Judd AM, MacLeod RM, Goodman DW, Isakson PC: Endotoxin-induced release of interlcukin-6 from rat medial basal hypothalami, Endocrinology 1990:127:1779-1785.
26. Honegger J, Spagnoli A, Durso R, Navarra P, Tsagarakis S, Besser GM, Grossman AB: intcr-leukin-ip modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumor necrosis factor and intcrleukin-6 have no effect, Endocrinololgy 1991; 129:1275-1282.
27. Delitala G, Tomasi P, Virdis R: Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man, Baillidre’s Clin Endocrinol 1987;1:391-414.
28. Bartalena L, Farsettit A, Flink IL, Robbins J: Effects of IL-6 on the expression of thyroid hormone-binding protein genes in cultcred human hepatoblastoma-derived (HepG2) cells, Mol Endocrinol 1992;6:935-942.
29. Boelcn A, Platvoetter Schiphorst MC, Wier-singa WM: Association between scrum inter-lcukin-6 and serum 3.5,3'-Triiodothyronine in nonthyroidal illness, J Clin Endocrinol Metab 1993;77:1695-1699.
30. Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T: The relationship between serum levels of intcrleukin-6 and thyroid hormone in children with acute respiratory infection, J Clin Endocrinol Metab 1994:78:288-291.
31. Doctor R, Krenning EP, De Jong M, Henne-mann G: The sick euthyroid syndrome: Changes in thyroid hormone serum parameters and hormone metabolism, Clin Endocrinol (OxO) 1993,39:499-518.
32. Wartofsky L, Burman KD: Alterations in thyroid function in patients with systemic illness: The ‘euthyroid sick syndrome’, Endocr Rev 1982:3:164-217.
33. Pang XP, Hershman JM, Mirell CJ, Pekary AE: Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-alpha (ca-chcctin), Endocrinology 1989:125:76-84.
34. Vander Poll T, Romijn JA, Wicrsinga WM, Sauerwcin HP: Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man, J Clin Endocrinol Metab 1990;71: 1567-1572.
35. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG: Human recombinant interleukin-lß decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats, Endocrinology, 1988;123:2175-2181.
36. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M: Transient hypogonadotropic hypogonadism caused by critical illness, J Clin Endocrinol Metab 1985;60:444-450.
37. Spangelo BL, MacLeod M, Isakson P: Production of interlcukin-6 by anterior pituitary cells in vitro, Endocrinology 1990;126:582-586.
38. Imura H, Fukata J: Endocrine-paracrinc interaction in communication between the immune and endocrine systems, Activation of the hypo-thalamic-pituitary-adrcnal axis in inflammation, EurJ Endocrinol 1994; 130:32-37.